Fair Value Measurements - Additional Information (Details) - USD ($) |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2019 |
Dec. 31, 2020 |
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
| Changes in estimated fair value of contingent consideration | $ 0 | |
| Changes in estimated contingent consideration initial value | 100,000 | |
| Aronora Royalty Purchase Agreement[Member] | ||
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
| Changes in estimated fair value of contingent consideration | 0 | |
| Changes in estimated contingent consideration initial value | $ 3,000,000 | |
| Rezolute [Member] | Common Stock Purchase Agreement [Member] | Forecast [Member] | ||
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
| Maximum number of shares of common stock sold back | 5,000,000 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Changes in estimated fair value of contingent consideration. No definition available.
|
| X | ||||||||||
- Definition Changes in estimated fair value of contingent consideration initial value. No definition available.
|
| X | ||||||||||
- Definition Maximum number of shares stock in Rezolute that can be sold back to Rezolute after 12/31/19. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|